operose health limited
operose health limited Company Information
Company Number
10014577
Registered Address
108 high street, great missenden, HP16 0BG
Industry
Other human health activities
Telephone
02039173496
Next Accounts Due
33 days late
Group Structure
View All
Shareholders
t20 osprey midco ltd 100%
operose health limited Estimated Valuation
Pomanda estimates the enterprise value of OPEROSE HEALTH LIMITED at £120.4m based on a Turnover of £112.1m and 1.07x industry multiple (adjusted for size and gross margin).
operose health limited Estimated Valuation
Pomanda estimates the enterprise value of OPEROSE HEALTH LIMITED at £78.3m based on an EBITDA of £8.3m and a 9.42x industry multiple (adjusted for size and gross margin).
operose health limited Estimated Valuation
Pomanda estimates the enterprise value of OPEROSE HEALTH LIMITED at £127.5m based on Net Assets of £53.7m and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Operose Health Limited Overview
Operose Health Limited is a live company located in great missenden, HP16 0BG with a Companies House number of 10014577. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2016, it's largest shareholder is t20 osprey midco ltd with a 100% stake. Operose Health Limited is a young, mega sized company, Pomanda has estimated its turnover at £112.1m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Operose Health Limited Health Check
Pomanda's financial health check has awarded Operose Health Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
5 Weak
Size
annual sales of £112.1m, make it larger than the average company (£851k)
£112.1m - Operose Health Limited
£851k - Industry AVG
Growth
3 year (CAGR) sales growth of 310%, show it is growing at a faster rate (4.7%)
310% - Operose Health Limited
4.7% - Industry AVG
Production
with a gross margin of 28.3%, this company has a comparable cost of product (35%)
28.3% - Operose Health Limited
35% - Industry AVG
Profitability
an operating margin of -4.4% make it less profitable than the average company (7.5%)
-4.4% - Operose Health Limited
7.5% - Industry AVG
Employees
with 1600 employees, this is above the industry average (20)
1600 - Operose Health Limited
20 - Industry AVG
Pay Structure
on an average salary of £39.3k, the company has a higher pay structure (£24.7k)
£39.3k - Operose Health Limited
£24.7k - Industry AVG
Efficiency
resulting in sales per employee of £70k, this is more efficient (£48.3k)
£70k - Operose Health Limited
£48.3k - Industry AVG
Debtor Days
it gets paid by customers after 43 days, this is later than average (24 days)
43 days - Operose Health Limited
24 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is slower than average (16 days)
23 days - Operose Health Limited
16 days - Industry AVG
Stock Days
it holds stock equivalent to 3 days, this is less than average (9 days)
3 days - Operose Health Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (106 weeks)
5 weeks - Operose Health Limited
106 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 64.3%, this is a higher level of debt than the average (26.7%)
64.3% - Operose Health Limited
26.7% - Industry AVG
OPEROSE HEALTH LIMITED financials
Operose Health Limited's latest turnover from December 2022 is £112.1 million and the company has net assets of £53.7 million. According to their latest financial statements, Operose Health Limited has 1,600 employees and maintains cash reserves of £3.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Turnover | 112,070,000 | 89,165,000 | 750,000 | 1,625,000 | 5,953,000 | 1,921,502 | 17,354 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 80,369,000 | 68,622,000 | 818,000 | 935,000 | 4,212,000 | 1,059,525 | 0 |
| Gross Profit | 31,701,000 | 20,543,000 | -68,000 | 690,000 | 1,741,000 | 861,977 | 17,354 |
| Admin Expenses | 36,660,000 | 26,475,000 | 9,942,000 | 7,797,000 | 3,817,000 | 3,655,739 | 2,286,676 |
| Operating Profit | -4,959,000 | -5,932,000 | -10,010,000 | -7,107,000 | -2,076,000 | -2,793,762 | -2,269,322 |
| Interest Payable | 1,999,000 | 1,831,000 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 689,000 | 685,000 | 678,000 | 677,000 | 614,000 | 133,527 | 77,886 |
| Pre-Tax Profit | -6,286,000 | -7,077,000 | -9,351,000 | -6,421,000 | -1,462,000 | -2,660,235 | -2,191,436 |
| Tax | 792,000 | -2,131,000 | -38,000 | -28,000 | 61,000 | -12,321 | 50,895 |
| Profit After Tax | -5,494,000 | -9,208,000 | -9,389,000 | -6,449,000 | -1,401,000 | -2,672,556 | -2,140,541 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -5,522,000 | -9,265,000 | -9,389,000 | -6,449,000 | -1,401,000 | -2,672,556 | -2,140,541 |
| Employee Costs | 62,895,000 | 53,628,000 | 4,608,000 | 5,060,000 | 3,566,000 | 1,101,230 | 0 |
| Number Of Employees | 1,600 | 1,383 | 33 | 56 | 70 | 19 | |
| EBITDA* | 8,312,000 | 6,406,000 | -9,833,000 | -6,915,000 | -1,924,000 | -2,760,784 | -2,269,322 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,382,000 | 2,592,000 | 186,000 | 95,000 | 0 | 0 | 0 |
| Intangible Assets | 102,608,000 | 110,587,000 | 857,000 | 789,000 | 271,000 | 303,389 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 11,243,996 | 11,243,996 |
| Debtors (Due After 1 year) | 14,991,000 | 14,455,000 | 13,017,000 | 12,398,000 | 11,745,000 | 34,051 | 20,864 |
| Total Fixed Assets | 119,981,000 | 127,634,000 | 14,060,000 | 13,282,000 | 12,016,000 | 11,581,436 | 11,264,860 |
| Stock & work in progress | 681,000 | 356,000 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 13,400,000 | 9,597,000 | 76,000 | 94,000 | 316,000 | 232,059 | 0 |
| Group Debtors | 160,000 | 50,000 | 6,000 | 2,000 | 0 | 258,258 | 124,730 |
| Misc Debtors | 13,986,000 | 10,186,000 | 122,000 | 78,000 | 141,000 | 1,216,200 | 48,336 |
| Cash | 3,505,000 | 7,773,000 | 1,373,000 | 605,000 | 2,282,000 | 1,009,921 | 324,294 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 31,732,000 | 27,962,000 | 1,577,000 | 779,000 | 2,739,000 | 2,716,438 | 497,360 |
| total assets | 151,713,000 | 155,596,000 | 15,637,000 | 14,061,000 | 14,755,000 | 14,297,874 | 11,762,220 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 34,000 | 39,000 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 5,192,000 | 2,997,000 | 245,000 | 13,000 | 0 | 0 | 0 |
| Group/Directors Accounts | 9,671,000 | 387,000 | 176,000 | 427,000 | 272,000 | 675,062 | 73,745 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 25,000 | 31,000 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 17,726,000 | 23,685,000 | 3,214,000 | 1,674,000 | 791,000 | 1,184,729 | 455,459 |
| total current liabilities | 32,648,000 | 27,139,000 | 3,635,000 | 2,114,000 | 1,063,000 | 1,859,791 | 529,204 |
| loans | 51,421,000 | 49,693,000 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 10,555,000 | 11,202,000 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 2,695,000 | 7,425,000 | 0 | 0 | 0 | 0 | 0 |
| provisions | 218,000 | 337,000 | 20,000 | 76,000 | 373,000 | 737,203 | 0 |
| total long term liabilities | 64,889,000 | 68,657,000 | 20,000 | 76,000 | 373,000 | 737,203 | 0 |
| total liabilities | 97,537,000 | 95,796,000 | 3,655,000 | 2,190,000 | 1,436,000 | 2,596,994 | 529,204 |
| net assets | 53,679,000 | 59,331,000 | 11,982,000 | 11,871,000 | 13,319,000 | 11,700,880 | 11,233,016 |
| total shareholders funds | 53,679,000 | 59,331,000 | 11,982,000 | 11,871,000 | 13,319,000 | 11,700,880 | 11,233,016 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | -4,959,000 | -5,932,000 | -10,010,000 | -7,107,000 | -2,076,000 | -2,793,762 | -2,269,322 |
| Depreciation | 585,000 | 512,000 | 40,000 | 13,000 | 0 | 0 | 0 |
| Amortisation | 12,686,000 | 11,826,000 | 137,000 | 179,000 | 152,000 | 32,978 | 0 |
| Tax | 792,000 | -2,131,000 | -38,000 | -28,000 | 61,000 | -12,321 | 50,895 |
| Stock | 325,000 | 356,000 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 8,249,000 | 21,067,000 | 649,000 | 370,000 | 10,461,432 | 1,546,638 | 193,930 |
| Creditors | 2,195,000 | 2,752,000 | 232,000 | 13,000 | 0 | 0 | 0 |
| Accruals and Deferred Income | -6,606,000 | 31,673,000 | 1,540,000 | 883,000 | -393,729 | 729,270 | 455,459 |
| Deferred Taxes & Provisions | -119,000 | 317,000 | -56,000 | -297,000 | -364,203 | 737,203 | 0 |
| Cash flow from operations | -4,000,000 | 17,594,000 | -8,804,000 | -6,714,000 | -13,082,364 | -2,853,270 | -1,956,898 |
| Investing Activities | |||||||
| capital expenditure | 0 | 0 | |||||
| Change in Investments | 0 | 0 | 0 | 0 | -11,243,996 | 0 | 11,243,996 |
| cash flow from investments | 0 | 0 | |||||
| Financing Activities | |||||||
| Bank loans | -5,000 | 39,000 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 9,284,000 | 211,000 | -251,000 | 155,000 | -403,062 | 601,317 | 73,745 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 1,728,000 | 49,693,000 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -6,000 | 31,000 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -4,730,000 | 7,425,000 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||
| interest | -1,310,000 | -1,146,000 | 678,000 | 677,000 | 614,000 | 133,527 | 77,886 |
| cash flow from financing | 4,831,000 | 112,867,000 | 9,927,000 | 5,833,000 | 3,230,058 | 3,875,264 | 13,525,188 |
| cash and cash equivalents | |||||||
| cash | -4,268,000 | 6,400,000 | 768,000 | -1,677,000 | 1,272,079 | 685,627 | 324,294 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,268,000 | 6,400,000 | 768,000 | -1,677,000 | 1,272,079 | 685,627 | 324,294 |
operose health limited Credit Report and Business Information
Operose Health Limited Competitor Analysis
Perform a competitor analysis for operose health limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in HP16 area or any other competitors across 12 key performance metrics.
operose health limited Ownership
OPEROSE HEALTH LIMITED group structure
Operose Health Limited has 1 subsidiary company.
Ultimate parent company
2 parents
OPEROSE HEALTH LIMITED
10014577
1 subsidiary
operose health limited directors
Operose Health Limited currently has 3 directors. The longest serving directors include Ms Caroline Bailes (May 2019) and Mr Edward McKenzie-Boyle (May 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Caroline Bailes | 54 years | May 2019 | - | Director | |
| Mr Edward McKenzie-Boyle | England | 43 years | May 2023 | - | Director |
| Mr Nicholas Harding | England | 54 years | Mar 2024 | - | Director |
P&L
December 2022turnover
112.1m
+26%
operating profit
-5m
-16%
gross margin
28.3%
+22.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
53.7m
-0.1%
total assets
151.7m
-0.02%
cash
3.5m
-0.55%
net assets
Total assets minus all liabilities
operose health limited company details
company number
10014577
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
February 2016
age
8
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2022
previous names
centene uk limited (November 2019)
accountant
DAVID SIMPSON
auditor
KPMG LLP
address
108 high street, great missenden, HP16 0BG
Bank
-
Legal Advisor
-
operose health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to operose health limited. Currently there are 2 open charges and 0 have been satisfied in the past.
operose health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
